The role of combination therapy in the management of hypertension
Open Access
- 1 June 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (6) , 1469-1473
Abstract
Data from the largest meta-analysis of hypertensive patients clearly demonstrate that increasing systolic blood pressure (BP) in any age group is associated with very significant increases in cardiovascular disease [1]. It has been shown that for every 20 mmHg increase in systolic BP, or for every 10 mmHg increase in diastolic BP, there is a doubling in the risk of cardiovascular disease. Conversely, a meta-analysis of outcome studies in the treatment of systolic hypertension demonstrated that for every 20 mmHg reduction in systolic BP there is an ∼40–45% reduction in cardiovascular disease [2]. These studies have confirmed the very significant cardiovascular risk associated with hypertension and the impressive benefits that can be derived from the treatment of this disease process. Despite these findings, worldwide epidemiological data have shown that fewer than one-third of hypertensive patients achieve a BP of <140/90 mmHg [3].Keywords
This publication has 14 references indexed in Scilit:
- Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazideAmerican Journal of Hypertension, 2004
- Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000JAMA, 2003
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Cardiovascular protection and blood pressure reduction: a meta-analysisThe Lancet, 2001
- Characteristics of Patients with Uncontrolled Hypertension in the United StatesNew England Journal of Medicine, 2001
- Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertensionClinical Cardiology, 2001
- Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertensionAmerican Journal of Hypertension, 1999
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- A Multifactorial Trial Design to Assess Combination Therapy in HypertensionArchives of internal medicine (1960), 1994